Molecular Clustering Results
==================================================
Total number of drugs: 377
Total number of clusters: 18

Cluster 0:
  Drug Count: 23
  Most Common MOA: inhibitor/antagonist
  Drugs: Adenosine, Clofarabine, Dapagliflozin, Cytarabine, 5-Azacytidine, Cytarabine hydrochloride, Brivudine, Arbutin, Trifluridine, Entecavir monohydrate...

Cluster 1:
  Drug Count: 21
  Most Common MOA: unclear
  Drugs: Estrone sulfate potassium, Dihydroartemisinin, Artesunate, Quinestrol, Digitoxin, Drospirenone, Triamcinolone, Eplerenone, Ouabain Octahydrate, Abiraterone acetate...

Cluster 2:
  Drug Count: 51
  Most Common MOA: inhibitor/antagonist
  Drugs: Tirabrutinib, Cobimetinib, Piroxicam, 4EGI-1, Adagrasib, DT-061, AZD2858, Levobupivacaine hydrochloride, Filgotinib, Tofacitinib citrate...

Cluster 3:
  Drug Count: 12
  Most Common MOA: Unknown
  Drugs: R-Verapamil hydrochloride, Isocorydine, Homoharringtonine, Berberine chloride hydrate, Sinomenine, Berbamine dihydrochloride, Palmatine chloride, Harringtonine, Ivabradine hydrochloride, Verapamil...

Cluster 4:
  Drug Count: 11
  Most Common MOA: Unknown
  Drugs: Ivermectin, Epirubicin hydrochloride, Demeclocycline, Erythromycin, Doxycycline monohydrate, Azithromycin hydrate, Tetracycline hydrochloride, Plicamycin, Idarubicin hydrochloride, Doxorubicin hydrochloride...

Cluster 5:
  Drug Count: 8
  Most Common MOA: inhibitor/antagonist
  Drugs: Neratinib maleate, Lapatinib ditosylate, Gefitinib, Vandetanib, Afatinib, Erlotinib, Neratinib, Simotinib

Cluster 6:
  Drug Count: 19
  Most Common MOA: inhibitor/antagonist
  Drugs: DTP3, Belumosudil mesylate, Goserelin acetate, Bestatin, Saquinavir, Atazanavir sulfate, Daptomycin, Bestatin hydrochloride, Pemetrexed, Bortezomib...

Cluster 7:
  Drug Count: 6
  Most Common MOA: inhibitor/antagonist
  Drugs: NG25, Selinexor, Flumatinib mesylate, Ponatinib, NVP-BHG712, Radotinib

Cluster 8:
  Drug Count: 37
  Most Common MOA: inhibitor/antagonist
  Drugs: LJI308, Temuterkib, Fostamatinib disodium hexahydrate, Ribociclib, Imiquimod maleate, Quinidine 15 dihydroquinidine, Dinaciclib, Imiquimod hydrochloride, Volasertib, Pemigatinib...

Cluster 9:
  Drug Count: 3
  Most Common MOA: inhibitor/antagonist
  Drugs: Everolimus, Temsirolimus, Rapamycin

Cluster 10:
  Drug Count: 2
  Most Common MOA: inhibitor/antagonist
  Drugs: vincristine, Vinblastine sulfate

Cluster 11:
  Drug Count: 3
  Most Common MOA: Unknown
  Drugs: Irinotecan hydrochloride, Irinotecan, Topotecan hydrochloride

Cluster 12:
  Drug Count: 3
  Most Common MOA: Unknown
  Drugs: Almonertinib hydrochloride, Almonertinib mesylate, Osimertinib mesylate

Cluster 13:
  Drug Count: 3
  Most Common MOA: Unknown
  Drugs: S-Crizotinib, crizotinib, Crizotinib hydrochloride

Cluster 14:
  Drug Count: 115
  Most Common MOA: inhibitor/antagonist
  Drugs: XRK3F2, Vitamin K4, Terfenadine, Sodium Salicylate, Belinostat, Oxaliplatin, Aliskiren, Captopril, Econazole, Loperamide hydrochloride...

Cluster 15:
  Drug Count: 3
  Most Common MOA: inhibitor/antagonist
  Drugs: Docetaxel, Docetaxel Trihydrate, Paclitaxel

Cluster 16:
  Drug Count: 3
  Most Common MOA: unclear
  Drugs: 18Î²-Glycyrrhetinic acid, Diammonium Glycyrrhizinate, Glycyrrhizic acid

Cluster 17:
  Drug Count: 54
  Most Common MOA: inhibitor/antagonist
  Drugs: Nevirapine, Capmatinib, Encorafenib, Celecoxib, ERK5-IN-2, BI-78D3, Bosentan hydrate, Fedratinib hydrochloride hydrate, EX229, Vortioxetine...

